{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:55:06Z","timestamp":1793498106014,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejim.2026.106931","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:14:57Z","timestamp":1778300097000},"page":"106931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Infectious complications of ANCA-associated vasculitis: Description and associated outcome"],"prefix":"10.1016","volume":"152","author":[{"given":"Jeanne","family":"Morin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Andr\u00e9","family":"Jarrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Solignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7212-190X","authenticated-orcid":false,"given":"Flora","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1396-5296","authenticated-orcid":false,"given":"Philippe","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Kaplanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Torrents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Faraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Jourde-Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-0372","authenticated-orcid":false,"given":"Micka\u00ebl","family":"Bobot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106931_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.106931_bib0002","article-title":"Protocole national de diagnostic et de Soins - Vascularites n\u00e9crosantes syst\u00e9miques","year":"2019","journal-title":"P\u00e9riart\u00e9rite Noueuse Et Vascularites Associ\u00e9es Aux ANCA"},{"key":"10.1016\/j.ejim.2026.106931_bib0003","doi-asserted-by":"crossref","first-page":"763","DOI":"10.34067\/KID.0007142020","article-title":"Treatment updates in antineutrophil cytoplasmic autoantibodies (ANCA) vasculitis","volume":"2","author":"Jain","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.ejim.2026.106931_bib0004","first-page":"65","article-title":"Pathophysiology of ANCA-associated vasculitis","volume":"56","author":"Lenka","year":"2020","journal-title":"Cesk Patol"},{"key":"10.1016\/j.ejim.2026.106931_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.revmed.2019.10.334","article-title":"[ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis]","volume":"41","author":"Philip","year":"2020","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ejim.2026.106931_bib0006","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nephro.2020.07.142","article-title":"pr\u00e9valence et mortalit\u00e9 des vascularites associ\u00e9es aux ANCA en France entre 2010 et 2018","volume":"16","author":"Bataille","year":"2020","journal-title":"N\u00e9phrologie Th\u00e9rapeutique"},{"key":"10.1016\/j.ejim.2026.106931_bib0007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.ejim.2026.106931_bib0008","doi-asserted-by":"crossref","DOI":"10.1007\/s40620-023-01855-x","article-title":"The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study","author":"Christodoulou","year":"2024","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejim.2026.106931_bib0009","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.3390\/ijms25105278","article-title":"Pathogenesis of pulmonary manifestations in ANCA-associated vasculitis and goodpasture syndrome","volume":"25","author":"Fouka","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2026.106931_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5152\/eujrheum.2022.20248","article-title":"Updates in ANCA-associated vasculitis","volume":"9","year":"2022","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106931_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103212","article-title":"Anti-glomerular basement membrane vasculitis","volume":"22","author":"Ponticelli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106931_bib0012","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.37765\/ajmc.2021.88746","article-title":"Antineutrophil cytoplasmic antibody (ANCA) vasculitis: pathophysiology, diagnosis, and the evolving treatment landscape","volume":"27","author":"Koening","year":"2021","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ejim.2026.106931_bib0013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/gfx378","article-title":"Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"34","author":"McAdoo","year":"2019","journal-title":"Nephrol Dial TransPl"},{"key":"10.1016\/j.ejim.2026.106931_bib0014","first-page":"944","article-title":"ANCA-associated vasculitis-treatment standard","volume":"39","author":"Chalkia","year":"2024","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.ejim.2026.106931_bib0015","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"Kidney Disease: improving global outcomes (KDIGO) ANCA vasculitis work group. KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2026.106931_bib0016","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106931_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185880","article-title":"Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial","volume":"12","author":"Maritati","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2026.106931_bib0018","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus Azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106931_bib0019","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106931_bib0020","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.34067\/KID.0000000000000222","article-title":"Low-dose intravenous methylprednisolone in remission induction therapy for ANCA-associated vasculitis","volume":"4","author":"Floyd","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.ejim.2026.106931_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018748","article-title":"Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial","volume":"7","author":"Furuta","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejim.2026.106931_bib0022","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/rheumatology\/kez575","article-title":"Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French vasculitis study group","volume":"59","author":"Lafarge","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.ejim.2026.106931_bib0023","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106931_bib0024","first-page":"1655","article-title":"Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis","volume":"38","author":"S\u00e1nchez \u00c1lamo","year":"2023","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.ejim.2026.106931_bib0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jbspin.2020.06.005","article-title":"Granulomatosis with polyangiitis (Wegener\u2019s)","volume":"87","author":"Pu\u00e9chal","year":"2020","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.ejim.2026.106931_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002424","article-title":"Association between different infection profiles and one-year outcomes in ANCA-associated vasculitis: a retrospective study with monthly infection screening","volume":"8","author":"Xu","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ejim.2026.106931_bib0027","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2026.106931_bib0028","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106931_bib0029","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/oxfordjournals.qjmed.a068882","article-title":"Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM Mon J Assoc Physicians"},{"key":"10.1016\/j.ejim.2026.106931_bib0030","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pr"},{"key":"10.1016\/j.ejim.2026.106931_bib0031","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.ejim.2026.106931_bib0032","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12882-018-0933-2","article-title":"Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study","volume":"19","author":"Yang","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ejim.2026.106931_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002424","article-title":"Association between different infection profiles and one-year outcomes in ANCA-associated vasculitis: a retrospective study with monthly infection screening","volume":"8","author":"Xu","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ejim.2026.106931_bib0034","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard-2022-223401","article-title":"Risk factors for serious infections in ANCA-associated vasculitis","volume":"82","author":"Odler","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2026.106931_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103713","article-title":"Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis","volume":"24","author":"Luo","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2026.106931_bib0036","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","article-title":"Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Rathmann","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.ejim.2026.106931_bib0037","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019173","article-title":"Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: A retrospective observational study","volume":"99","author":"Waki","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2026.106931_bib0038","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3899\/jrheum.190065","article-title":"Prevalence and risk factors for major infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis: influence on the disease outcome","volume":"47","author":"Garcia-Vives","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2026.106931_bib0039","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/rheumatology\/keab469","article-title":"Mortality and cause of death in patients with ANCA-associated vasculitis and polyarteritis nodosa in Australia-a population-based study","volume":"61","author":"Tieu","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.ejim.2026.106931_bib0040","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.ejim.2026.106931_bib0041","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00296-020-04661-x","article-title":"Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study with a clinical phenotype approach","volume":"40","author":"Caballero-Islas","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ejim.2026.106931_bib0042","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/eci.12410","article-title":"Frequency, risk factors and prophylaxis of infection in ANCA -associated vasculitis","volume":"45","author":"Kronbichler","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2026.106931_bib0043","doi-asserted-by":"crossref","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","article-title":"Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function","volume":"30","author":"McGregor","year":"2015","journal-title":"Nephrol Dial TransPl"},{"key":"10.1016\/j.ejim.2026.106931_bib0044","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2215\/CJN.03190321","article-title":"Disease activity and adverse events in patients with ANCA-associated vasculitides undergoing long-term dialysis","volume":"16","author":"Kauffmann","year":"2021","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.ejim.2026.106931_bib0045","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106931_bib0046","first-page":"321","article-title":"The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: a retrospective study","volume":"41","author":"Fonseca","year":"2021","journal-title":"Nefrol Engl Ed"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:41:56Z","timestamp":1790840516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0953620526002360"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106931","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious complications of ANCA-associated vasculitis: Description and associated outcome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106931"}}